Search by Drug Name or NDC

NDC 00703-5075-01 Dacarbazine 200 mg/20mL Details

Dacarbazine 200 mg/20mL

Dacarbazine is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is DACARBAZINE.

MedlinePlus Drug Summary

Dacarbazine is used to treat melanoma (a type of skin cancer) that has spread to other parts of your body. Dacarbazine is also used in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease; a type of cancer that begins in a type of white blood cells that normally fights infection). Dacarbazine is in a class of medications known as purine analogs. It works by slowing or stopping the growth of cancer cells in your body.

Related Packages: 00703-5075-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dacarbazine

Product Information

NDC	00703-5075
Product ID	0703-5075_46f32b94-ccdf-42ce-a41c-60f929479db8
Associated GPIs	21700020002110
GCN Sequence Number	008834
GCN Sequence Number Description	dacarbazine VIAL 200 MG INTRAVEN
HIC3	V1F
HIC3 Description	ANTINEOPLASTICS,MISCELLANEOUS
GCN	38731
HICL Sequence Number	003927
HICL Sequence Number Description	DACARBAZINE
Brand/Generic	Generic
Proprietary Name	Dacarbazine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Dacarbazine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, POWDER, FOR SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	200
Active Ingredient Units	mg/20mL
Substance Name	DACARBAZINE
Labeler Name	Teva Parenteral Medicines, Inc.
Pharmaceutical Class	Alkylating Activity [MoA], Alkylating Drug [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA075259
Listing Certified Through	n/a

Package

NDC 00703-5075-01 (00703507501)

Pricing Information	N/A
NDC Package Code	0703-5075-01
Billing NDC	00703507501
Package	1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5075-01) / 20 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date	1998-08-27
NDC Exclude Flag	N